Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (28)
Isabelle Kaiser, Katja Kauertz, Stefan K. Zöllner, Wolfgang Hartmann, Thorsten Langer, Heribert Jürgens, Andreas Ranft & Uta Dirksen. (2022) Secondary Malignancies after Ewing Sarcoma—Epidemiological and Clinical Analysis of an International Trial Registry. Cancers 14:23, pages 5920.
Crossref
Crossref
Stefanie J. Kube, Claudia Blattmann, Stefan S. Bielack, Leo Kager, Peter Kaatsch, Thomas Kühne, Benjamin Sorg, Matthias Kevric, Susanne Jabar, Erika Hallmen, Monika Sparber‐Sauer, Thomas Klingebiel, Ewa Koscielniak, Uta Dirksen, Stefanie Hecker‐Nolting & Joachim W. O. Gerß. (2022) Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults. Cancer 128:9, pages 1787-1800.
Crossref
Crossref
Anna Raciborska, Katarzyna Bilska, Tomasz Koziński & Carlos Rodriguez-Galindo. (2022) Subsequent Malignant Neoplasm of Bone in Children and Adolescent—Possibility of Multimodal Treatment. Current Oncology 29:2, pages 1001-1007.
Crossref
Crossref
Charlotte Ryder-Burbidge, Ruth L. Diaz, Ronald D. Barr, Sumit Gupta, Paul C. Nathan, Sarah J. McKillop & Miranda M. Fidler-Benaoudia. (2021) The Burden of Late Effects and Related Risk Factors in Adolescent and Young Adult Cancer Survivors: A Scoping Review. Cancers 13:19, pages 4870.
Crossref
Crossref
Sebastian Zahnreich & Heinz Schmidberger. (2021) Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies. Cancers 13:11, pages 2607.
Crossref
Crossref
Asle Charles Hesla, Andri Papakonstantinou & Panagiotis Tsagkozis. (2021) Current Status of Management and Outcome for Patients with Ewing Sarcoma. Cancers 13:6, pages 1202.
Crossref
Crossref
Asle Charles Hesla, Andrea Discacciati, Panagiotis Tsagkozis & Karin E. Smedby. (2020) Subsequent primary neoplasms among bone sarcoma survivors; increased risks remain after 30 years of follow-up and in the latest treatment era, a nationwide population-based study. British Journal of Cancer 122:8, pages 1242-1249.
Crossref
Crossref
Debra L. Friedman. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
741
750.e2
.
Anjani Kumar Jha, Pradeep Neupane, Manohar Pradhan, Krishna Sagar Sharma, Sadina Shrestha, Padma Raj Sigdel, Sigbjørn Smeland & Øyvind S. Bruland. (2019) Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy. Journal of Global Oncology:5, pages 1-10.
Crossref
Crossref
Diana Abbott, Schuyler O'Brien, James M. Farnham, Erin L. Young, Jeffrey Yap, Kevin Jones, Stephen L. Lessnick, R. Lor Randall, Joshua D. Schiffman & Lisa A. Cannon‐Albright. (2019) Increased risk for other cancers in individuals with Ewing sarcoma and their relatives. Cancer Medicine 8:18, pages 7924-7930.
Crossref
Crossref
Jennifer Caruso, David S. Shulman & Steven G. DuBois. (2019) Second malignancies in patients treated for Ewing sarcoma: A systematic review. Pediatric Blood & Cancer 66:11.
Crossref
Crossref
Ajay Puri, Ashish Gulia, Saniya Crasto, Tushar Vora, Nehal Khanna & Siddharth Laskar. (2018) Does Radiotherapy after Surgery Affect Outcomes in Ewing’s Sarcoma of the Pelvis?. Indian Journal of Orthopaedics 52:1, pages 73-76.
Crossref
Crossref
Albert Y. Lin & Evan T. Hall. (2017) Second malignancies in Ewing sarcoma survivors. Cancer 123:20, pages 4075-4075.
Crossref
Crossref
Neyssa M. Marina, Qi Liu, Sarah S. Donaldson, Charles A. Sklar, Gregory T. Armstrong, Kevin C. Oeffinger, Wendy M. Leisenring, Jill P. Ginsberg, Tara O. Henderson, Joseph P. Neglia, Marilyn A. Stovall, Yutaka Yasui, R. Lor Randall, David S. Geller, Leslie L. Robison & Kirsten K. Ness. (2017) Reply to Second malignancies in Ewing sarcoma survivors. Cancer 123:20, pages 4075-4076.
Crossref
Crossref
Philip J. Lupo, Austin L. Brown & Simone Hettmer. (2016) Second malignancy risk among pediatric, adolescent, and young adult survivors of fusion-positive and fusion-negative sarcomas: Results from the SEER database, 1992 through 2012. Cancer 122:22, pages 3492-3500.
Crossref
Crossref
Stéphanie Foulon, Bernadette Brennan, Nathalie Gaspar, Uta Dirksen, Lee Jeys, Anna Cassoni, Line Claude, Beatrice Seddon, Perrine Marec-Berard, Jeremy Whelan, Michael Paulussen, Arne Streitbuerger, Odile Oberlin, Heribert Juergens, Robert Grimer & Marie-Cécile Le Deley. (2016) Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group. European Journal of Cancer 61, pages 128-136.
Crossref
Crossref
Tara O. HendersonChaya S. MoskowitzJoanne F. ChouAngela R. BradburyJoseph Phillip NegliaChau T. DangKenan OnelDanielle Novetsky FriedmanSmita BhatiaLouise C. StrongMarilyn StovallLisa B. KenneyDana BarneaElena LorenziSue HammondWendy M. LeisenringLeslie L. RobisonGregory T. ArmstrongLisa R. DillerKevin C. Oeffinger. (2016) Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. Journal of Clinical Oncology 34:9, pages 910-918.
Crossref
Crossref
Asle Charles Hesla, Panagiotis Tsagozis, Nina Jebsen, Olga Zaikova, Henrik Bauer & Otte Brosjö. (2016) Improved Prognosis for Patients with Ewing Sarcoma in the Sacrum Compared with the Innominate Bones. Journal of Bone and Joint Surgery 98:3, pages 199-210.
Crossref
Crossref
Matthew S Ning, Stephanie M Perkins, Scott C Borinstein, Ginger E Holt, Mark J Stavas & Eric T Shinohara. (2016) Role of radiation in the treatment of non-metastatic osseous Ewing sarcoma. Journal of Medical Imaging and Radiation Oncology 60:1, pages 119-128.
Crossref
Crossref
Fabian Wolpert, Michael A. Grotzer, Felix Niggli, Dieter Zimmermann, Elisabeth Rushing & Beata Bode-Lesniewska. (2016) Ewing’s Sarcoma as a Second Malignancy in Long-Term Survivors of Childhood Hematologic Malignancies. Sarcoma 2016, pages 1-11.
Crossref
Crossref
Rachael Caffrey, Andrew J. Robinson, Satyen Shukla, Heather McCarty, Alastair Brown & Oisín P. Houghton. (2014) Metachronous Myxofibrosarcoma and Osteosarcoma. International Journal of Surgical Pathology 23:2, pages 149-155.
Crossref
Crossref
Anna Raciborska, Katarzyna Bilska, Magdalena Rychlowska-Pruszynska, Katarzyna Drabko, Radosław Chaber, Monika Pogorzała, Katarzyna Połczyńska, Jan Godziński, Carlos Rodriguez-Galindo & Wojciech Wożniak. (2014) Internal hemipelvectomy in the management of pelvic Ewing sarcoma – are outcomes better than with radiation therapy?. Journal of Pediatric Surgery 49:10, pages 1500-1504.
Crossref
Crossref
Manabu Hoshi, Makoto Ieguchi, Kazumi Yamato, Sadao Tokimasa & Hiroaki Nakamura. (2014) Diagnosis of osteosarcoma in a patient previously treated for Ewing sarcoma. Skeletal Radiology 43:9, pages 1319-1324.
Crossref
Crossref
Min Rex Cheung. (2014) Optimization of Predictors of Ewing Sarcoma Cause-specific Survival: A Population Study. Asian Pacific Journal of Cancer Prevention 15:10, pages 4143-4145.
Crossref
Crossref
Debra L. Friedman. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
894
903.e3
.
Mark A. Applebaum, Robert Goldsby, John Neuhaus & Steven G. DuBois. (2012) Clinical features and outcomes in patients with secondary Ewing sarcoma. Pediatric Blood & Cancer 60:4, pages 611-615.
Crossref
Crossref
Harald Paganetti, Basit S Athar, Maryam Moteabbed, Judith A Adams, Uwe Schneider & Torunn I Yock. (2012) Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field. Physics in Medicine and Biology 57:19, pages 6047-6061.
Crossref
Crossref
Joshua D. Schiffman & Jennifer Wright. (2011) Ewing's Sarcoma and Second Malignancies. Sarcoma 2011, pages 1-8.
Crossref
Crossref